메뉴 건너뛰기




Volumn 37, Issue 11, 2001, Pages 1352-1358

A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma

Author keywords

5 Fluorouracil; Chemotherapy; Eniluracil; Inoperable hepatocellular carcinoma

Indexed keywords

5 ETHYNYLURACIL; ANTHRACYCLINE; FLUOROURACIL;

EID: 0034954843     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00100-9     Document Type: Conference Paper
Times cited : (26)

References (30)
  • 4
  • 6
    • 0029001687 scopus 로고
    • A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
    • (1995) New Engl J Med , vol.332 , pp. 1256-1261
  • 7
    • 0031801297 scopus 로고    scopus 로고
    • Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma. Results of a randomized controlled trial in a single institution
    • (1998) Hepatology , vol.27 , pp. 1578-1583
    • Bruix, J.1    Llovet, J.M.2    Castells, A.3
  • 15
    • 10544243363 scopus 로고    scopus 로고
    • Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase
    • (1996) J Clin Oncol , vol.14 , pp. 3085-3096
    • Baker, S.D.1    Khor, S.P.2    Adjei, A.A.3
  • 16
    • 0033975358 scopus 로고    scopus 로고
    • Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil
    • (2000) J Clin Oncol , vol.18 , pp. 915-926
    • Baker, S.D.1    Diasio, R.B.2    O'Reilly, S.3
  • 23
    • 50549174560 scopus 로고
    • The determination of the number of patients required in a preliminary and follow-up trial of a new chemotherapeutic agent
    • (1961) J Chron Dis , vol.13 , pp. 346-353
    • Gehan, E.A.1
  • 24


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.